These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6099520)

  • 1. Failure to demonstrate mu-isoreceptors.
    Rourke JD; Shaw JS
    Neuropeptides; 1984 Dec; 5(1-3):85-8. PubMed ID: 6099520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine.
    Wood PL; Pasternak GW
    Neurosci Lett; 1983 Jun; 37(3):291-3. PubMed ID: 6310456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF; Lewis RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):467-70. PubMed ID: 6298890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxonazine actions in vivo.
    Ling GS; Simantov R; Clark JA; Pasternak GW
    Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meptazinol: a novel Mu-1 selective opioid analgesic.
    Spiegel K; Pasternak GW
    J Pharmacol Exp Ther; 1984 Feb; 228(2):414-9. PubMed ID: 6141283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of morphine's analgesic and respiratory depressant actions.
    Ling GS; Spiegel K; Nishimura SL; Pasternak GW
    Eur J Pharmacol; 1983 Jan; 86(3-4):487-8. PubMed ID: 6299765
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged mu- and delta-receptor occupancy may result in naloxone-reversible respiratory depression and naloxone-irreversible antinociception.
    Freye E; Schenk G
    Prog Clin Biol Res; 1990; 328():379-84. PubMed ID: 2154797
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions.
    Pick CG; Paul D; Pasternak GW
    Life Sci; 1991; 48(21):2005-11. PubMed ID: 1851915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects.
    Pasternak GW
    Ann N Y Acad Sci; 1986; 467():130-9. PubMed ID: 3014970
    [No Abstract]   [Full Text] [Related]  

  • 16. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW; Pasternak GW; Faden AI
    Neurosci Lett; 1983 Jun; 37(2):199-204. PubMed ID: 6308526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system.
    Pasternak GW; Gintzler AR; Houghten RA; Ling GS; Goodman RR; Spiegel K; Nishimura S; Johnson N; Recht LD
    Life Sci; 1983; 33 Suppl 1():167-73. PubMed ID: 6319856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermorphin tetrapeptide analog induces naloxonazine-reversible respiratory stimulation.
    Paakkari P; Paakkari I; Feuerstein G
    Prog Clin Biol Res; 1990; 328():385-8. PubMed ID: 2154798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.